Literature DB >> 16257544

IABs scientific workshop on neurovirulence tests for live virus vaccines, January 31-February 1, 2005, Geneva.

.   

Abstract

Mesh：

Substances：

Year:  2005        PMID： 16257544     DOI： 10.1016/j.biologicals.2005.08.005

Source DB:  PubMed          Journal:  Biologicals        ISSN： 1045-1056            Impact factor:   1.856


× No keyword cloud information.
  8 in total

1.  Neuropathogenesis and neurovirulence of live flaviviral vaccines in monkeys.

Authors:  Inessa Levenbook; Ken Draper
Journal:  J Virol       Date:  2009-05       Impact factor: 5.103

2.  High-throughput automated image analysis of neuroinflammation and neurodegeneration enables quantitative assessment of virus neurovirulence.

Authors:  Olga A Maximova; Brian R Murphy; Alexander G Pletnev
Journal:  Vaccine       Date:  2010-08-03       Impact factor: 3.641

3.  Comparative neuropathogenesis and neurovirulence of attenuated flaviviruses in nonhuman primates.

Authors:  Olga A Maximova; Jerrold M Ward; David M Asher; Marisa St Claire; Brad W Finneyfrock; James M Speicher; Brian R Murphy; Alexander G Pletnev
Journal:  J Virol       Date:  2008-03-19       Impact factor: 5.103

4.  Genetic contributions to influenza virus attenuation in the rat brain.

Authors:  Li Qi; Kathryn M Carbone; Zhiping Ye; Teresa Liu; Mikhail Ovanesov; Mikhail Pletnikov; Christian Sauder; Steven A Rubin
Journal:  J Neurovirol       Date:  2008-04       Impact factor: 2.643

5.  A mouse-based assay for the pre-clinical neurovirulence assessment of vaccinia virus-based smallpox vaccines.

Authors:  Cheryl X Zhang; Christian Sauder; Tahir Malik; Steven A Rubin
Journal:  Biologicals       Date:  2009-11-06       Impact factor: 1.856

6.  WHO Working Group on Technical Specifications for Manufacture and Evaluation of Yellow Fever Vaccines, Geneva, Switzerland, 13-14 May 2009.

Authors:  Morag Ferguson; Jinho Shin; Ivana Knezevic; Philip Minor; Alan Barrett
Journal:  Vaccine       Date:  2010-11-04       Impact factor: 3.641

7.  Recombinant vesicular stomatitis vaccine against Nipah virus has a favorable safety profile: Model for assessment of live vaccines with neurotropic potential.

Authors:  Thomas P Monath; Richard Nichols; Lynda Tussey; Kelly Scappaticci; Thaddeus G Pullano; Mary D Whiteman; Nikos Vasilakis; Shannan L Rossi; Rafael Kroon Campos; Sasha R Azar; Heidi M Spratt; Brent L Seaton; W Tad Archambault; Yanina V Costecalde; Evan H Moore; Roger J Hawks; Joan Fusco
Journal:  PLoS Pathog       Date:  2022-06-27       Impact factor: 7.464

Review 8.  Live Viral Vaccine Neurovirulence Screening: Current and Future Models.

Authors:  Corey May Fulton; Wendy J Bailey
Journal:  Vaccines (Basel)       Date:  2021-06-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.